Literature DB >> 8270270

Bovine herpesvirus-1 vaccines.

S van Drunen Littel-van den Hurk1, S K Tikoo, X Liang, L A Babiuk.   

Abstract

Vaccination has been important in controlling a wide variety of viral and bacterial infections of man and animals. Vaccines to herpesvirus infection of cattle are no exception. The present review describes the different types of conventional vaccines that have been used to date and furthermore describes the novel approaches which are presently being implemented to develop more effective vaccines. These include subunit vaccines as well as genetically engineered modified live deletion mutants. Both these novel vaccine approaches appear to be more efficacious than conventional vaccines. Furthermore, these vaccines provide an additional dimension for control and eradication of infection by providing an opportunity to develop companion diagnostic tests to differentiate infected animals from vaccinated animals. This review summarizes these developments as well as present knowledge regarding the important host defence mechanisms required for preventing infection and aiding recovery from infection.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8270270     DOI: 10.1038/icb.1993.47

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  11 in total

1.  Altering the cellular location of an antigen expressed by a DNA-based vaccine modulates the immune response.

Authors:  P J Lewis; L A Babiuk
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

2.  Expression of human immunodeficiency virus type 1 gp120 from herpes simplex virus type 1-derived amplicons results in potent, specific, and durable cellular and humoral immune responses.

Authors:  Peter K Hocknell; Rebecca D Wiley; Xiuqing Wang; Thomas G Evans; William J Bowers; Tomas Hanke; Howard J Federoff; Stephen Dewhurst
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

3.  Latency-related gene encoded by bovine herpesvirus 1 promotes virus growth and reactivation from latency in tonsils of infected calves.

Authors:  Sandra Perez; Melissa Inman; Alan Doster; Clinton Jones
Journal:  J Clin Microbiol       Date:  2005-01       Impact factor: 5.948

4.  Prediction of potential cytotoxic T lymphocyte epitopes of bovine herpesvirus 1 based on allele-specific peptide motifs and proteolytic cleavage specificities.

Authors:  N R Hegde; S Srikumaran
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

5.  Replication-defective bovine adenovirus type 3 as an expression vector.

Authors:  P S Reddy; N Idamakanti; Y Chen; T Whale; L A Babiuk; M Mehtali; S K Tikoo
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

6.  Efficacy of an experimental BHV-1 subunit gIV vaccine in beef calves challenged with BHV-1 in aerosol.

Authors:  J Van Donkersgoed; D McCartney; S van Drunen Littel-van den Hurk
Journal:  Can J Vet Res       Date:  1996-01       Impact factor: 1.310

7.  Expression of the genomic form of the bovine viral diarrhea virus E2 ORF in a bovine herpesvirus-1 vector.

Authors:  Lingshu Wang; J Charles Whitbeck; William C Lawrence; Denys V Volgin; Leonard J Bello
Journal:  Virus Genes       Date:  2003-08       Impact factor: 2.332

8.  A hepadnavirus regulatory element enhances expression of a type 2 bovine viral diarrhea virus E2 protein from a bovine herpesvirus 1 vector.

Authors:  Lingshu Wang; Sreekumar Menon; Steven R Bolin; Leonard J Bello
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

9.  Immunization of cattle with recombinant Newcastle disease virus expressing bovine herpesvirus-1 (BHV-1) glycoprotein D induces mucosal and serum antibody responses and provides partial protection against BHV-1.

Authors:  Sunil K Khattar; Peter L Collins; Siba K Samal
Journal:  Vaccine       Date:  2010-02-26       Impact factor: 3.641

10.  Bovine herpesvirus type 1 (BHV-1) UL49.5 luminal domain residues 30 to 32 are critical for MHC-I down-regulation in virus-infected cells.

Authors:  Huiyong Wei; Ying Wang; Shafiqul I Chowdhury
Journal:  PLoS One       Date:  2011-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.